Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transformation Capital is a leading venture capital and growth equity firm focused on investing in digital health and healthcare technology companies that are transforming the delivery of care. The fund backs innovative businesses across digital health infrastructure, AI-driven platforms for providers and payers, virtual care models, data analytics for biopharma and hospitals, pharmacy benefit management technology, and more. It does not develop drugs or have its own clinical pipeline but supports portfolio companies with proven experience and industry networks. Transformation Capital does not develop drugs or therapies itself, so fields related to pipeline programs/modalities/targets do not apply. Its relevance to life sciences comes from investing heavily into digital transformation technologies used throughout the healthcare ecosystem—including those supporting pharma R&D/commercialization via portfolio companies like Scientist.com and Aktana.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Transformation Capital.